Enrotron 50 mg/ml Solution for injection for cattle, sheep, goats, pigs, dogs and cats

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

Enrofloxacin

제공처:

aniMedica GmbH

ATC 코드:

QJ01MA90

INN (International Name):

Enrofloxacin

복용량:

50 milligram(s)/millilitre

약제 형태:

Solution for injection

처방전 유형:

POM: Prescription Only Medicine as defined in relevant national legislation

치료 영역:

enrofloxacin

승인 상태:

Authorised

승인 날짜:

2012-04-20

제품 특성 요약

Enrotron 50 mg/ml
1 von 18
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Enrotron 50 mg/ml Solution for injection for cattle, sheep, goats,
pigs, dogs and cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE
Enrofloxacin
50.0 mg
EXCIPIENTS
1-Butanol
30.0 mg
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear, slightly yellowish to yellowish orange solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (calves)
Sheep
Goats
Pigs
Dogs
Cats
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
_ _
CALVES
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of
_Pasteurella multocida, Mannheimia haemolytica_
and
_Mycoplasma _
spp.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of
_Escherichia coli_
.
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli_
.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin
susceptible strains of
_Mycoplasma bovis_
.
SHEEP
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of
_Escherichia coli. _
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli. _
Treatment of mastitis caused by enrofloxacin susceptible strains of
_Staphylococcus aureus _
and
_Escherichia coli. _
_ _
_ _
Enrotron 50 mg/ml
2 von 18
GOATS
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptible strains of
_Pasteurella multocida _
and
_Mannheimia haemolytica_
.
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of
_Escherichia coli. _
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli_
.
Treatment of mastitis caused by enrofloxacin susceptible strains of
_Staphylococcus aureus _
and
_Escherichia coli. _
PIGS
Treatment of infections of the respiratory tract caused by
enrofloxacin susceptib